For the latest on Thailand Medical Industry, Thailand Doctors, Thailand Medical Research, Thailand Hospitals, Thailand Wellness Initiatives and the latest Medical News
Source: University Of Michigan Apr 12, 2019 7 years ago
Human papillomavirus infection rates are increasing in women born after 1980 who did not receive the HPV vaccine—putting them at higher risk for HPV-related cancers, according to a University of Michigan study.
While more than 90 percent of HPV-related cancers are preventable, HPV causes more than 40,000 cases of cancer in the United States each year and about 1.8 million cases globally, ...
Source: Thailand Medical News Apr 02, 2019 7 years ago
Siriraj Hospital in Thailand, lead by Dr Vuthinun Achariyapota announced at the recent Society Of Gynecologic Cancers (SGO) Annual Meeting 2019 in Hawaii of a new novel approach of detecting HPV via urine samples.
HPV Virus
The group from Siriraj Hospital initially conducted a study from a sample size of about 96 women. In the study, two methods of detecting high-grade squamous intraepit...
Source: University of Alabama at Birmingham Mar 02, 2019 7 years ago
In a paper recently published in the Journal of Infectious Diseases, researchers examined the effect of vaginal tenofovir 1 percent gel use on the risk of acquiring herpes simplex virus type 2, or HSV-2. The study was conducted through a secondary analysis of data from the VOICE study.
According to the Centers for Disease Control and Prevention, more than one in six Americans ages 14 to 49 ...
Source: Thailand Medical News Feb 17, 2019 7 years ago
Updated treatment guidelines and the availability of the ResistancePlus GC test for Neisseria gonorrhoeae, from SpeeDx Inc, Sydney, Australia, are making it possible for some UK patients with gonorrhea to be treated with the cheap and easily-administered oral antibiotic ciprofloxacin.
Ciprofloxacin was the first-line antibiotic of choice for uncomplicated gonorrhea in the ...
Source: University Of Waterloo Feb 07, 2019 7 years ago
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.
Chlamydia in a human cell.
The new treatment differs from the traditional anti-biotic treatment as it is a type of gene therapy that is delivered via nanotechnology and is showing a 65 per cent success rate in preventing c...
An often-overlooked type of STD, oral gonorrhea presents a challenge for healthcare in Thailand and globally. The threat this bacterial infection poses is not limited to the disease itself – there are large-scale public health issues related both to long-term inflammation by an infection in the throat or mouth left untreated and to the wrongful prescription of certain antibiotics that give r...
Source: The Wellcome Trusts Jan 27, 2019 7 years ago
New diseases emerge all the time, and sexually transmitted infections are no exception. Here are four bacteria that could become serious public health threats. Already the infection rates are steadily increasing and worst in Asia, where a lot of people are not even aware of themselves contracting these infections or lack access to proper diagnostics or treatments and also complacency among doctors...
Source: Johns Hopkins University Jan 01, 2019 7 years ago
A new test for chlamydia can provide results within 30 minutes, potentially speeding up the start of treatment, researchers say.
The rapid test for the sexually transmitted disease means patients can receive treatment immediately, instead of having to wait for a follow-up appointment. This could help reduce the spread of the disease, according to researchers at Johns Hopkins Universit...
Source: University Of Connecticut Nov 06, 2018 7 years ago
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible.
Syphilis Bacteria
The World Health Organization estimates that 40.7 million people between the ages of 15 and 49 had syphilis in 2017, and about 7.6 million people contract it every year. In the U.S....
Source: The University of Manchester Oct 25, 2018 7 years ago
What causes Alzheimer's disease? The answer could be right under our noses, says leading expert Professor Ruth Itzhaki. Her latest paper presents a lifetime of research evidence that the herpes virus responsible for cold sores can also cause Alzheimer's -- and new data which show antiviral drugs drastically reduce risk of senile dementia in patients with severe herpes infections. The revie...
Source: European Centre for Disease Prevention and Control (ECDC) Sep 06, 2018 8 years ago
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriax...
Source: US Centers for Disease Control and Prevention Aug 28, 2018 8 years ago
Despite rising vaccination rates, cancers related to human papillomavirus, a common sexually transmitted infection, are on the rise in the United States, particularly cancers of the head, neck and throat, officials said Thursday.
In men, most of the increase was in head, neck and throat cancers, while in women, cases of HPV-related anal cancer rose, according to a report ...
Source: Cancer Research UK Aug 08, 2018 8 years ago
It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in the UK to help protect against the virus that causes most cases of cervical cancer. But until now, it has only been routinely offered to girls.
Today, the Joint Committee for Vaccination and Immunisation (JCVI) recommended that adolescent boys should now also receive the vaccine.
...
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.
If patients develop resistance to these drugs, there are even fewer choices left to treat the infection, which lasts for life.
BX795
Researchers at the University of Illinois at Chicago have now identified a ...
Source: University of Connecticut Jul 21, 2018 8 years ago
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers report.
The World Health Organization estimates that 10.7 million people between the ages of 15 and 49 had syphilis in 2012, and about 5.6 million people cont...
Chlamydia trachomatis is the main cause of sexually transmitted diseases. More than 131 million people are infected with this bacterium worldwide. If detected at an early stage and treated with antibiotics the infection with Chlamydia can be treated very well. However, infections with Chlamydia develop often without symptoms therefore in many cases remain unnoticed. This promotes the spread o...
Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
The microbe, Neisseria gonorrhoeae
The findings, published today in PLOS Pathogens, are especially important since the microbe, Neisseria gonorrhoeae, is considered a "superbug" be...
The infection can be mistaken for chlamydia, but it's become resistant to traditional antibiotic treatments.
Doctors are warning about a sexually transmitted infection that could become the next hard-to-treat superbug, thanks to its increasing resistance to traditional antibiotics. They say that the infection, called Mycoplasma genitalium(also known as M. genital...
